Pamela Ann Connealy - 28 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
CFO and COO
Signature
/s/ Pamela Connealy
Issuer symbol
PYXS
Transactions as of
28 Sep 2023
Net transactions value
+$14,960
Form type
4
Filing time
28 Sep 2023, 16:32:03 UTC
Previous filing
27 Sep 2023
Next filing
30 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Purchase $14,960 +8,000 +0.99% $1.87 818,532 28 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased all 8,000 shares of common stock in the open market at a price of $1.87 per share.